You are here: All Products  > RemeGen Announces Positive Results for HER2 ADC in Urothelial Cancer

RemeGen Announces Positive Results for HER2 ADC in Urothelial Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products